Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group by Stella M. Davies, Michael J. Borowitz, Gary L. Rosner, Kristin Ritz, Meenakshi Devidas, Naomi Winick, Paul L. Martin, Paul Bowman, James Elliott, Cheryl Willman, Soma Das, Edwin H. Cook, and Mary V. Relling Blood Volume 111(6):2984-2990 March 15, 2008 ©2008 by American Society of Hematology

Classification and regression tree (CART) for predictors influencing those patients destined to be in the “worst” versus “best” minimal residual disease (MRD). Classification and regression tree (CART) for predictors influencing those patients destined to be in the “worst” versus “best” minimal residual disease (MRD). Stella M. Davies et al. Blood 2008;111:2984-2990 ©2008 by American Society of Hematology